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Abstract
In recent years, many medically promising antibiotics have been discovered in nature,
especially in insect-microbe symbioses. One of the better-studied examples of this kind of
defensive

relationship is that of fungus-growing ants and the antibiotic-producing

Actinobacteria. These bacteria produce several defensive chemicals with myriad uses, including
one antibiotic that inhibits the growth of several bacterial strains, including other Actinobacteria.
This antibiotic (known as nocamycin O) is a promising candidate for medicinal use due to its
similarities to bacterial RNA polymerase inhibitors tirandamycin and streptolydigin, which
inhibit several human pathogens. The determination of the structure of nocamycin O will be an
important first step toward determining its function and its potential utility in the medical field.
This can be done efficiently and accurately using nuclear magnetic resonance spectroscopy
(NMR). NMR can be used on its own to attempt to solve the structure of a compound, or in
tandem with virtual chemical shift calculations that act as a check to correct the
experimentally-derived structure. Overall, NMR and chemical shift calculations have become
integral components to biochemical and biomedical research because they make structure
elucidation much easier. My research sought to confirm the structure of nocamycin O using prior
NMR data for the compound, as well as novel 2D NMR data collected in MeOD and DMSO
with complementary 13
 C-NMR spectrum calculations performed using DFT in Spartan ‘18.
Comparative analysis of NMR spectra for nocamycin O and nocamycin I revealed key
differences in chemical shift values; the carbon with the additional -OH in nocamycin O
experienced a shift change of almost 40 ppm, while other carbons in the molecule showed a
change of 5-10 ppm. These changes were likely due to a difference in nuclear environment at
these positions, which was confirmed via the DFT calculations and ROESY spectrum.
3

Introduction
Novel Antibiotic Discovery: Methods
Over the last few decades, more and more highly antibiotic-resistant pathogenic bacteria
have been discovered. This necessitates the introduction and use in medicine of new antibiotics
that bacteria have not yet evolved to resist. However, the rate of approval of new antibiotics has
not kept pace with need and has decreased dramatically in the last twenty years.1 The most
common traditional methods of antibiotic discovery are discovery-based chemical screening
(screening small molecules for a certain desired activity without prior knowledge of their
functions), and target-oriented screening (focused on identifying compounds that attack a known
target), but these methods have grown ineffective.2 The slowdown may be due to the rediscovery
of many already-known substances, as it appears that certain classes of molecules are more likely
to be discovered in these types of screening campaigns. To combat that, combinatorial chemistry
was created, which involves in silico screening of fragments and experimental screening of
fragment libraries followed by linkage of promising fragments in hope of creating a functional
and useful drug.3 However, though many new chemical compounds have been discovered, few
have proven at all useful in terms of antibiotic or antifungal activity. This is because the
combinatorial chemistry methods appear to only cover a limited amount of the chemical
diversity represented in most chemical libraries.2 Most drugs currently in use, as well as those
produced in nature, show a much more diverse representation of chemical types that have more
diverse and potent functions. The discovery of more of these diverse and well-functioning
compounds could be achieved through natural products discovery, but not in the traditional
sense. Instead of focusing on high-throughput screening or chimerically stitching two functional
parts together, the attention should be on finding more naturally-occurring compounds, in
4

particular from plants and microbes and especially from defensive symbioses. In recent years,
this type of natural products research has been the most productive in terms of new drug
discoveries to be tested. There are currently over 100 new naturally-derived drugs in clinical
development, mainly as cancer treatments and antibiotics.1

Nocamycin O as a Potential Antibiotic for Commercial Use
In terms of novel antibiotic discovery, insect-microbe symbioses have shown much
promise in recent years. These types of symbioses are common in many different types of
animals and can come in two forms. Nutritional symbioses imply that the bacteria either
produces nutrients the host needs or aids with digestion, while defensive symbiosis usually
means that the bacteria produces a chemical that the host weaponizes for its own defense.4-7 One
of the more promising and better-studied examples of this kind of defensive relationship is that
of fungus-growing ants and the antibiotic-producing Actinobacteria. The bacteria live off of
secretions produced by the ant, and in return, they manufacture a wide variety of molecules with
demonstrated antibacterial properties.7,8 The presence of Actinobacteria h as been shown to
correlate with the efficacy of the ants’ efforts to suppress attacks by the pathogen Escovopsis,
which feeds upon the cultivar fungus that is the ants’ main food source (Figure 1). Antifungal
molecules were also isolated from strains of Streptomyces found in similar fungus gardens on the
same types of ants; their general function is suppression of nest pathogens, and they represent an
exciting new area of study.7,8

5

Figure 1: Graphic representation of the symbiotic relationship between fungus-growing
ants and some strains of Actinobacteria, adapted from Kim et. al. (2019).
A particularly interesting facet of this symbiosis is that most strains of Actinobacteria
show strong antagonistic effects against other Actinobacteria s trains isolated from different ants.
This is likely because when they coexist in the same environment, Actinobacteria a re in direct
competition with each other to maintain their favorable position in the symbiosis. This is
well-illustrated in the response of Trachymyrmex septentrionalis- associated Actinobacteria t o
other types of Actinobacteria.9 Most of the bacterial isolates coming from T. septentrionalis
show weak or no inhibition of other types of Actinobacteria also associated with other T.
septentrionalis a nts and extremely strong inhibition of the other Actinobacteria 17SM-1 and
18AZ-4, which come from T. smithi and T. arizonensis ants respectively.9 All of the strains that
showed any inhibition at all were able to efficiently inhibit the growth of other types of
Actinobacteria a nd many Gram-positive bacteria including the human pathogens Staphylococcus
aureus and Enterococcus faecalis.9 The fact that the paradigm of this particular defensive
symbiosis parallels human medicine (both use antagonistic molecules like antibiotics to suppress
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pathogens) and that molecules associated with this paradigm have been shown to inhibit growth
of human pathogens is exciting because it represents an ecologically-guided pathway to
discovering new antibiotics with a higher probability of success in humans, as they are already
compatible with animal hosts.7
One such antibiotic is nocamycin O, an analog of nocamycin I (also known as
BU-2313B). It was isolated from a bacterium in the genus Amycolatopsis, a symbiont of
Trachymyrmex smithi that is another type of Actinobacteria. Four different isolates of
Amycolatopsis were tested by Rose Kim (a previous researcher in the Van Arnam Lab) for
potential antibiotic activity; the most inhibitory isolate, 17SM-2, was selected for further study.
This strain was subjected to resident-intruder assays to determine whether the compound it
produced had antifungal or antibacterial activity (Figure 2):

Figure 2: Resident-intruder assays to evaluate antifungal (left) and antibacterial (right) activity
in 17SM-2, from Kim et. al. (2019).
The antibacterial compound was extracted from the bacteria and then fractionated, first using
C18 chromatography and then high-performance liquid chromatography (HPLC). The most
active fraction was then subjected to liquid chromatography-high resolution mass spectrometry
(LC-HRMS). This analysis showed a (M+H)+ peak of 520.2187, which gives a molecular mass
of 519.2133 +/- 0.0051. Additionally, no matches were found in the Dictionary of Natural
Products, indicating that this antibiotic is possibly a novel find.11 Similarities between nocamycin
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I data and preliminary MS data for nocamycin O support the idea that it belongs to the
nocamycin family (Figure 3). The strongest support for this idea, however, comes from
biosynthetic gene cluster analysis; >75% of the genes encoding nocamycin I are very similar to
genes for nocamycin O, and all genes except one have an analog in the other genome. One- and
two-dimensional NMR (nuclear magnetic resonance) experiments were used to elucidate a
tentative structure.

Figure 3: Mass spectrometry results with tentative structure for (A) nocamycin O and
(B) nocamycin I. nocamycin I data from Cogan et. al. (2020).
8

Since the mechanisms of nocamycin I and O inhibition have not been well studied,
research on similar molecules was conducted to gain a better idea of ways in which these
molecules could potentially inhibit bacterial growth. Chemically similar (and better
characterized) relatives include tirandamycin and streptolydigin, also part of the tetramic acid
family. It has been well-documented that streptolydigin inhibits bacterial growth by interfering
with bacterial RNA polymerase by binding to its Stl pocket, bridge helix, and trigger-loop
regions; part of its structure is close enough to contact the backbone of the DNA nontemplate
strand, allowing streptolydigin to interfere with RNAP function through direct interactions with
the DNA.12 This is relevant because while streptolydigin has a similar structure to the nocamycin
family, it is different enough that the binding affinity and properties may be much different.
Nocamycins I and II are unique from the rest of the family in that they have a fused tricyclic ring
system, while others such as streptolydigin and tirandamycin have a bicyclic system (Figure 4).

Figure 4: Structure comparison of nocamycin O (A), nocamycin I (B), streptolydigin (C),
and tirandamycin (D).
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Streptolydigin is a known inhibitor of bacterial RNA polymerase in a number of Gram-positive
bacteria. Nocamycin I (the closest chemical relative to nocamycin O) also demonstrates broad
antimicrobial activity against many Gram-positive and a few Gram-negative bacteria.13-15 These
bacteria include the two anaerobes Bacteroides fragilis and Propionibacterium acnes and the
aerobe Streptococcus pyogenes, a known cause of infections such as tonsillitis, scarlet fever,
cellulitis, and necrotizing fasciitis in humans.13,14 Additionally, it was noted that increasing the
size or chain length of the 5’ substituent (a synthetic addition to the the CH2 carbon in the
tetramic acid ring) led to a decrease in efficacy of the antibiotic, with the most effective synthetic
nocamycin I analog having a methyl substituent in the R1 position; it was still not as effective as
the original compound.14 This has implications for nocamycin activity in comparison to other
tetramic acid antibiotics like streptolydigin; most of those implications have to do with structure
and how the antibiotic associates with its target, bacterial RNA polymerase. Though it is
currently unknown how or whether nocamycin interacts with RNA polymerase to inhibit
bacterial growth, based upon its structural similarities to streptolydigin, our knowledge of how
streptolydigin interacts with RNA polymerase, and the similar activity profiles between the two
(both inhibit bacteria in the Streptococcus f amily and the Bacillus family, as well as Neisseria
meningitidis) , it is likely that the nocamycin family associates with RNA polymerase in a similar
fashion.12,16
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Figure 5: [1] streptolydigin (in purple) associating with bacterial RNAP and [2] all of its van
der Waals interactions (blue dashes) and hydrogen bonds (green arrows) with RNAP, from
Temiakov et. al. (2005).
It has been suggested that the streptolol portion (the portion containing the bicyclic ring
system) of streptolydigin is the main determinant of its affinity for RNA polymerase; the
tetramic acid portion of the molecule has no specific binding sites on the protein surface and thus
15
cannot contribute to its interactions with RNA polymerase, and may even weaken them.
The

sugar moiety (the six-membered ring containing carbons 1”-5” in Figure 4) also has no contact
with RNA polymerase; it may even hinder streptolydigin binding by competing for positions
with other parts of RNA polymerase.15 Nocamycin O lacks both a bulky tetramic acid portion
and a sugar moiety, as it contains only a five-membered nitrogenous ring in that region (Figure
3). Assuming that nocamycin O maintains a similar conformation/orientation toward RNA
polymerase as streptolydigin upon binding with it, nocamycin O could potentially inhibit RNA
polymerase more efficiently than streptolydigin. The hydrogen bond with 𝛽R548 can be
maintained, as that part of nocamycin O is structurally identical to streptolydigin, and the
hydrogen bond lost by the replacement of the acetamide could easily be filled by the nitrogen in
the tetramic acid ring of nocamycin O. In addition, nocamycin O also contains an -OH group on
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one methyl substituent of the tricyclic system, which opens up the possibility of
additional/previously unobserved noncovalent interactions with the hydrophilic/polar amino
acids in that region of RNA polymerase (Figure 3). The combination of the less bulky tetramic
acid group and the additional hydrogen bonding opportunity implies that nocamycin O could be
an even stronger inhibitor of RNA polymerase than either nocamycin I or streptolydigin, and that
is has potential as an antibiotic against human pathogens as well. Additionally, there is already a
precedent for the addition of an -OH group at this position, as tirandamycin B, another tetramic
acid antibiotic, has this addition.17
As shown by the importance of chemical structure in the functioning of streptolydigin,
proper elucidation of chemical structure is an important first step in determining how a molecule
functions in vivo. Thus, proper determination of the structure of nocamycin O will be an integral
and enlightening step toward the discovery of its relationship with RNA polymerase and its
binding properties, as well as an integral component to its establishment as a novel molecule.
One method that has been briefly mentioned was selected for this task: NMR spectroscopy. The
utility of NMR spectroscopy and related theoretical models in terms of structure determination
will be discussed below.

NMR Spectroscopy and its Theoretical Supplements
NMR spectroscopy is useful for several reasons; it is a non-destructive technique (the
molecule does not decay after analysis), it has a wide range of applications in almost every
branch of science, and it has hundreds of different types of experiments meant to reveal different
aspects of the molecular structure.18 In the most basic sense, NMR involves exciting the nuclei of
the molecule in a specific way by generating a series of radiofrequency and/or magnetic gradient
12

pulses followed by signal acquisition to gather the desired information about the molecule. This
information can then be compiled into a readable format from which a molecular structure can be
obtained.
In an ideal situation, issues caused by suboptimal experimental environments and
background noise in NMR acquisition would be minimal, but in practice, the spectra obtained
depend a great deal on external factors, many of which are mechanical- or solvent-related.
Common causes of inaccuracy in chemical shift assignments include distorted or hidden peaks
caused by misplacement of the magnets (incorrect shimming) or poor signal-to-noise ratio,
insufficient acquisition time, and most importantly, broad peaks caused by decreased sensitivity
of the experiment due to insufficient sample volume.18 It is clear that spectral complexity
impedes proper structural determination in experimental NMR acquisition, and with larger
molecules, this issue is compounded due to the possibility of peaks appearing on top of each
other, a phenomenon known as spectral crowding. However, it should be noted that many of
these issues can be addressed by simply changing the modality or phase state of the experiment.
Many problems associated with 1-dimensional solution-state NMR can be fixed either by
transitioning to solid-state NMR or by performing multiple 2-dimensional experiments, as these
will show where couplings occur on the crowded 1H-NMR spectrum. In addition, theoretical
calculations can be used to help confirm shift assignments by showing what the shift values for
each nucleus in a structure should be under various solvent conditions.

NMR Theory and the Importance of Chemical Shift Calculations in Structure Determination
Presently, computational chemistry software packages are becoming more widely known
as valid alternatives and complements to the experimental methods used to perform certain
13

experiments and calculations. These include energetics calculations, molecular structure
optimizations, and calculation of the values of various molecular characteristics, including their
IR (infrared) and NMR spectra. With theoretical calculations, the issues of spectral complexity
and suboptimal experimental conditions are eliminated. Additionally, NMR chemical shift
calculations are an excellent way to confirm the structure proposed by the experimental data.
NMR spectra are created based on the specific behavior of each NMR-active nucleus in the
molecule in response to an external magnetic field, in this case, a large magnet.19 The central
question that NMR helps answer is the determination of chemical structure; assigning shift
values to each atom in the molecule can help confirm that structure. The basic principle
underlying NMR and all theoretical models based upon it is that the frequency at which each
atom’s spin aligns with the external magnetic field is directly related to its chemical
environment. The frequency at which each atom resonates can be altered by a change to its
environment, and depending on what changes, can be positive or negative.19,20 Shielding is
caused by the electron cloud surrounding each atom; when the external magnetic field is applied,
the field it induces directly opposes it, which reduces the strength of the external magnetic field
in that location.20 Being bonded to more electronegative atoms causes electron density to be
siphoned away from that specific nucleus, resulting in less of a shielding effect and an increase
in the shift value.21 The shift value of each nucleus is a value in ppm (a standardized unit, parts
per million, that allows for values taken on different spectrometers to be the same) which is
usually between 0 and 14 for protons, and directly depends on the frequency (in hertz) that
causes the atom to align with the external field; more shielded atoms will respond to lower
frequencies and thus have a lower ppm value.20

14

An even smaller deviation in the magnetic field can be observed due to the orientation of
other nearby atoms of the same type. Essentially, while the external magnetic field affects the
resonant frequency of each nucleus, so do the induced magnetic fields of the nearby atoms.19,20
Each of these factors depend on the electron density around each atom as well as the way these
electrons affect the local magnetic environment, two things that empirical methods (which assign
chemical shifts based on prior experimentally-determined values for chemically-similar nuclei)
fail to account for because they generally ignore electronic contributions. Thus, quantum
chemical methods such as density functional theory, discussed later in this section, become
necessary in order to account for these small but important indirect interactions in the overall
energy of the molecule.
Empirical methods for calculating shifts involve extrapolation of experimental
knowledge; data are usually taken from chemical shift tables for each unique molecular
environment, adjusted based on electronegativity trends, and averaged over the different
conformers of the molecule to give each atom a unique value in the NMR spectrum.19 Other
methods involve a mass search of molecule databases to find molecular environments which are
chemically similar to the atom currently being analyzed; the advantage of these methods is that
each can be performed and completed quickly. However, these empirically-based models have
drawbacks; when the differences in chemical shift are too small, the program cannot reliably
distinguish between individual magnetic signals, making this type of calculation less useful for
large molecules like biopolymers and antibiotics. Quantum-mechanical calculations, the primary
calculation format found in this thesis, use an entirely different approach to predict the chemical
shifts of the target molecule than empirical methods; this source is primarily the electronic
structure of the molecule.19 While empirical methods use previously acquired data and
15

chemically similar matches to construct an NMR spectrum, quantum mechanical calculations use
the electronic structure to determine the magnetic shielding and spin-spin coupling constants,
interactions which are determined solely by the electronic structure of the molecule (Figure 6).

Figure 6:Taylor series describing the energy of the molecule in terms of the electronic structure
including magnetic shielding (Ei(11)) and spin-spin coupling (Eij(02)), from Gryff-Keller (2011).
In Figure 6, B and μ are quantities describing the magnetic field and nuclear magnetic
moments, two quantities which are necessary for calculating the magnetic shielding and coupling
constants. These are integral for the accurate calculation of the shift value for each nucleus due
to the utilization of the electronic structure as outlined above. Therefore, these quantities cannot
be measured using simple analytical techniques; due to the complexity of the connection
between these parameters and the electronic structure, connections cannot be made between
spin-spin coupling (small deviations in the field due to signals produced by neighboring atoms),
magnetic shielding, and other well-defined NMR parameters using empirical methods.19 Though
quantum mechanical calculations come with their own set of issues (first and foremost an
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extremely slow processing rate), a quantum mechanical perspective is helpful for linking NMR
parameters to molecular structure.
The major principles used in NMR shift calculations are based upon principles of
quantum mechanics as applied to molecules, a subset of quantum mechanics known as quantum
chemistry, whose theories underlie the programs used in computational chemistry. This involves
the application of mathematical and theoretical principles to the solution of chemical problems
and can be used to calculate values for chemical properties virtually.22 Two broader areas of
quantum chemistry are statistical mechanics and electronic structure theory; of these, the more
relevant in terms of NMR spectra is electronic structure theory. Electronic structure theory
utilizes the laws of quantum mechanics rather than classical mechanics to mathematically
calculate the energy and related properties of molecules while taking into account the atoms’
electrons, something that molecular mechanics and empirical methods do not do. The only form
of electronic structure calculations that are entirely quantum theory-based are known as ab initio
calculations; one of the most commonly used methods in general and the one most often used in
terms of this thesis is density functional theory, or DFT.
Density functional theory (hereafter abbreviated as DFT) appears here to offer a
compelling alternative to more computationally-taxing methods like Hartree-Fock, which
involves the approximation of the Schrödinger equation via a complex multivariable wave
function 𝛹 (x1,x2,...,x N ) .19,23 It simplifies the solution to the Schrödinger equation by employing a
simpler method to calculate the energies; in DFT, the N-electron wave function and the
associated Schrodinger equation are replaced with the simpler electron density equation 𝜌(r) and
its associated calculational scheme (Figure 7):
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Figure 7: [1] representing the energy of an atom in terms of its electron density, and [2] the
ground-state energy with respect to 𝜌, from Parr and Yang (1995).
Figure 7 shows an equation for the energy of an atom that depends only on the electron
density; the Hohenberg-Kohn theorems modified that further to say that it determines all
properties of the ground state, including the kinetic (T[𝜌]), potential (V[𝜌]), and total (E[𝜌])
energies.23 It is important to note that it is impossible to have a true value of FHK[𝜌], the universal
functional (a function that takes another function as its input) of 𝜌(r), which is notoriously
difficult to explicitly calculate. However, approximations are fairly easy to do if one assumes
that the value of FHK[𝜌] in a uniform electron gas translates well to real systems.24 Following the
calculation of E[𝜌], the energies with respect to the nuclear magnetic moment μ and the external
magnetic field B (as seen in Figure 6) can be compared to the ground-state energy in the absence
of these variables, E0, and the same theoretical model (in this case, DFT) is then used to generate
a simulated NMR spectrum. The calculated chemical shift values for the tentative structure can
then be plotted against the experimentally determined shift values to make certain that the
structure and shift value assignments are correct.

NMR in Practice
In practice, NMR spectra are much easier to understand than the theoretical calculations
required to simulate them. The principle behind NMR spectroscopy is very similar to that of the
fluorescence of light; when an external magnetic field is applied, each NMR-active nucleus can
align their spins either with or against or the magnetic field. When the nuclei are in the xy-plane,
18

the signal will be visible. As the nucleus relaxes back to align with the z-axis, its signal decays;
the different rates at which the nuclei relax and its immediate environment account for
differences in signal intensity and chemical shift value, respectively. The surroundings for each
atom play a role as well. For both 1H- and 13
 C-NMR (the most often-analyzed nuclei in NMR), as
more electron density is shifted away from the nucleus in question, the higher the chemical shift
gets (Figure 8). Certain functional groups will consistently cause higher shift values, making
NMR useful for identifying functional groups and determining molecular structure.

Figure 8: H-NMR spectrum of ethyl benzoate to illustrate chemical shift, from Balci (2005).
The splitting of the peaks seen in Figure 8 has to do with the spin orientation of
neighboring nuclei, also known as spin-spin coupling. The pattern has to do with the number of
different nuclei in the immediate vicinity of the nucleus; the CH2 will be split three times (into a
quartet) because its only immediate hydrogen neighbor is the methyl group.25 Once the spectral
pattern of one type of nucleus is known, it can be used to assign another type of nucleus and
19

figure out structure and attachments through two-dimensional NMR, which is the correlation of
shift values for one type of nucleus with the shift values of another type of nucleus. For example,
certain two-dimensional experiments will align proton signals with the carbon signals in their
surrounding environments, giving information about which proton is attached to which carbon.
The most common and useful of these heteronuclear two-dimensional experiments are
Heteronuclear Single Quantum Coherence (HSQC) and Heteronuclear Multiple Bond Coherence
(HMBC).

Figure 9: Overlay of HSQC and HMBC spectrum of ethylbenzene, from Hoffman (2020).
Signals present on the HMBC that are absent on the HSQC are highlighted in red.
HSQC is one of many short-range heteronuclear correlation methods. It is especially
useful because it illustrates exactly which hydrogen is attached to which carbon. All correlation
signals not highlighted in Figure 9 make up the HQSC spectrum, where each hydrogen signal on
the horizontal axis has only one correlation to the carbon spectrum on the vertical axis because
hydrogen can only make one bond. Using this, one can assign hydrogens to their respective
carbons. HMBC is, as its name suggests, indicative of the carbon associations up to 4 bonds
away from each hydrogen atom, and can be used to illustrate the chemical environment of each
20

hydrogen.30,31 As seen in Figure 9, the hydrogens of the methyl group in ethylbenzene are
coupled to both the carbon in the benzylic position and the first carbon in the aromatic ring, and
this is especially useful because that carbon lacks hydrogens and so is invisible on the HSQC.
Using the HSQC and HMBC spectra in conjunction with the 1H spectrum and its splitting is
often enough to determine the connectivity of the atoms.
After the connectivity of the atoms is determined, additional spectra can be taken that are
useful for determining aspects of the molecule’s conformation and orientation in space, such as
cis/trans alkene structure. The experiment used to detect these changes is known as a ROESY
(rotating-frame Overhauser Effect spectroscopy) spectrum, which uses Nuclear Overhauser
Effects to detect small changes in inter- and intramolecular interactions.28 The Nuclear
Overhauser Effect can be defined as the enhancement of a spin signal due to the dipole-dipole
relaxation effect, or more simply, the spin of the excited nucleus relaxes because the
magnetization is transferred over to the other coupled nucleus in the pair.28 However, there is an
amount of artifact that can appear on a ROESY spectrum from protons that are coupled to each
other and are fairly similar in chemical shift due to transfer of the signal by proximity or proton
exchange.29 This can be remedied by also performing a TOCSY (Total Correlated Spectroscopy)
experiment, which is somewhat of a long-range COSY coupling experiment. Any protons that
show up there are then known to be artifacts on the ROESY.29 This technique is desirable for
discovering the intramolecular reactions as well as the conformation of medium-sized molecules
such as nocamycin O.
In cases where spectra are difficult to read due to spectral crowding or a poor signal to
noise ratio, more spectra may need to be taken in different solvents to fully understand the
connections between atoms. In some cases, peaks may even disappear due to proton exchange
21

with the solvent, so it becomes quite challenging to know if the preliminary structure is correct.
This is where the utility of chemical shift calculations using models like HF and DFT becomes
apparent. If the structure put into the model is inaccurate, the calculated shifts will reflect that,
and changes to the proposed structure can be made (and additional NMR experiments run to
confirm that the changes are correct). As a molecule gets larger, NMR structures become harder
to solve, and thus chemical shift calculations become more important. Given that most
biomolecules are somewhat larger and more complex than synthetically generated compounds,
both NMR and its theoretical counterpart are integral components in chemical and biochemical
research.
In order to fully understand the relationship between RNA polymerase and nocamycin O,
the molecular structure must be comprehensively elucidated. The definitive determination of the
structure of nocamycin O will be integral in a) determining its novelty, b) allowing us to
determine how this novelty impacts its interaction with its cellular target, and c) eventually
conducting trials against a number of pathogens to determine its value in the medical and
research fields. This study seeks to fully determine the nocamycin O structure using prior NMR
data collected by students in the Van Arnam lab along with novel 2D NMR data collected
between January and March of 2020, with complementary 13
 C-NMR chemical shift calculations
performed using Hartree-Fock and density functional theory.

Methods
NMR Data Acquisition in MeOD-d4
Prior to NMR acquisition, the purified nocamycin O was supplied by Elisabeth Lawton.
The nocamycin O was evaporated to dryness in a SpeedVac, held under an additional vacuum of
22

approximately 100 millitorr overnight, and redissolved in 200 mL of deuterated methanol
(MeOD-d4). All spectra were collected between the dates of February 13 and 28, 2020 on a 500
MHz Bruker BioSpin GmbH NMR instrument. Additionally, all spectra were collected between
294.6 and 298.1 K with a 5 mm TXI 1H/ D-13C/ 15N Z-GRD Z8161/ 0208 probe setting other
than the initial 1D carbon spectrum, which was collected by Elisabeth Lawton on October 7,
2019 with a 5 mm PABBO BB/ 19F-1H/ D Z-GRD Z109128/ 0109 probe setting and zgig30
pulse sequence. The second spectrum collected was a 1D proton spectrum, gathered using pulse
sequence zg30 with 32 scans. Following the initial proton spectrum, 5 other experiments were
performed: 2D COSY (pulse sequence cosygpppqf, 8 scans), 2D HSQC (pulse sequence
hsqcedetgpsp.3, 32 scans), 2D H2BC (pulse sequence h2bcetgpl3, 22 scans), 2D HMBC (pulse
sequence hmbcetgpl3nd, 62 scans), and 2D ROESY (pulse sequence roesyphpp.2, 14 scans,
relaxation delay 2.0 seconds). Following acquisition, all spectra were imported to and analyzed
using MestReNova v12.0.3-21384 software. All heteronuclear 2D experiments were analyzed
using the previously collected 13
 C spectrum as a reference (which was referenced to the solvent,
MeOD-d4), and the proton dimensions of all experiments were also referenced to the MeOD
hydrogen peak (a quintet centered at 3.31 ppm).

NMR Data Acquisition in DMSO-d6
The previously used sample (MeOD-d4) was evaporated to dryness in a SpeedVac,
redissolved in 1 mL of regular methanol (MeOH), and allowed to sit at room temperature for 16
hours so that proton exchange could occur. The sample was then re-evaporated to dryness on the
23

SpeedVac, further held under vacuum at approximately 100 millitorr for 15 hours, and finally
redissolved in 200 mL of DMSO. Additional NMR data was collected on the 500 MHz Bruker
BioSpin GmbH with probe setting 5 mm TXI 1H/ D-13C/ 15N Z-GRD Z8161/ 0208.
Temperature was not controlled for these experiments. The first spectrum collected was a 1D
proton spectrum (pulse sequence zg30, 32 scans), followed by a 2D HSQC (pulse sequence
hsqcedetgpsp.3, 32 scans), 2D HMBC (pulse sequence hmbcetgpl3nd, 64 scans), 2D COSY
(pulse sequence cosygpmfppqf, 32 scans), 2D H2BC (pulse sequence h2bcetgpl3, 96 scans), 2D
ROESY (pulse sequence roesyphpr.2, 32 scans, relaxation delay 2.0 seconds), and a 2D TOCSY
(pulse sequence mlevphpr.2, 32 scans). An attempt to capture a 1D carbon spectrum was
unsuccessful due to low probe sensitivity, so all spectra were referenced using the successful 1D
proton spectrum (which was referenced to the DMSO peak at 2.50 ppm) and the solvent peak
present in the carbon spectrum (the only definitive peak present at 39.50 ppm). All spectra were
analyzed in MestReNova v12.0.3-21384 and shift values were assigned.

Chemical Shift Calculations
Following initial NMR data acquisition, chemical shift calculations for the proposed
structure of nocamycin O as well as for the chemically similar compound nocamycin I were
generated. This was done using Spartan ’18 molecular modeling software and precisely followed
a procedure outlined by Hehre et. al. as summarized below.30
The first step was performed using a systematic or sparse-systematic conformational
search using the MMFF (Merck Molecular Force Field) molecular mechanics model to remove
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any extremely high-energy conformers present in the initial search; all conformers with energies
more than 40 kJ/mol above the lowest-energy conformer were discarded. In step 2, the
Hartree-Fock method was utilized along with the 3-21G basis set to calculate equilibrium
geometries for each conformer (between 20 and 25 are typically left at this stage). All
conformers outside of a 40 kJ/mol energy threshold were again eliminated, as well as any
duplicate conformers. In step 3, the ωB97X-D density functional model was used with the
6-31G* basis set to recalculate energies with a more accurate molecular model, and all
conformers with a relative energy greater than 15 kJ/mol were discarded.
Steps 4 and 5 endeavored to repeat steps 2 and 3 under stricter molecular models and
with more accurate basis sets. In step 4, the ωB97X-D density functional model was used with
the 6-31G* basis set to recalculate equilibrium geometries for the remaining conformers,
eliminating those with a relative energy greater than 10 kJ/mol. Step 5 recalculated conformer
energies (usually around 8 or 9 conformers are left at this stage) with the ωB97X-V density
functional model and the 6-311+G(2df,2p) dual basis set. After step 5, both 1H- and 13
 C-NMR
spectra were generated for all conformers with a relative energy less than 10 kJ/mol and each
shift value was averaged according to Boltzmann weight.

Results
NMR in MeOD and dDMSO - Experimental Results
The preliminary structure of nocamycin O was largely confirmed and supported by the
data gathered from the initial NMR structure analysis in MeOD (Figure 10):
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Figure 10: Spectral data for nocamycin O in MeOD (values obtained via 1D 1H- and 13
 C-NMR).
The initial data was mostly sufficient to prove most of the structure previously proposed as
correct; however, two issues were identified through the NMR data collection. The first problem
was that it was suspected that several 𝛼-hydrogens had been replaced with deuteriums. This is
most clearly seen in the signal for C-19, where no proton signals were observed (even though it
should show up as a CH2). This necessitated another round of data collection in an aprotic
solvent, which will be discussed later in this section. The second problem was the low
confidence of the chemical shift assignment at C-4, likely because of the scarcity of protons in
that region of the molecule. There were no HMBC, H2BC, or COSY signals coupled to that
carbon (Figure 11).

26

Figure 11: Key NMR correlations (COSY - green, HMBC - pink) in MeOD.
The HMBC and H2BC coupling signals were extensive and useful for confirming the tricyclic
structure of the upper part of the molecule. However, there is less evidence supporting the -OH
group at C-23, as C-19, which is adjacent, was not coupling to anything. This was due to proton
exchange at that location; however, the fact that the shift value of C-23 is greater than 60 ppm is
indicative of its likely attachment to an oxygen atom. The inability to confirm the existence of
the -OH group or the assignment at C-4 necessitated more data collection. dDMSO was chosen
as the aprotic solvent (as it easily dissolves water-insoluble compounds), and the compound was
redissolved, first in MeOH to reverse the proton exchange, and then in dDMSO. The same
spectra were obtained for the compound in dDMSO as in MeOD, with the addition of a TOCSY
spectrum. Spectral assignments as well as splitting and coupling constants for the proton
spectrum were determined (Figure 12).
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Figure 12: Spectral data for nocamycin O in dDMSO (values obtained via 1D 1H-NMR
and 2D HSQC).
Following the second round of data collection, the issues relating to insufficient data at
C-19 and C-23 were resolved. Both protons attached to the carbon at C-19 became visible
(though their splitting is somewhat unclear due to the dDMSO solvent peak present at 2.50 ppm
and the CH peak from H-21 at 2.88 ppm). The new visibility at C-19 means that all three CH2
carbons originally proposed to be a part of the structure are now fully confirmed, a finding that
can be corroborated by the phase-edited HSQC (in which all CH2 peaks show up as blue instead
of red). This increases the likelihood that nocamycin O is a novel member of the nocamycin
family (the spectrum for nocamycin I, its nearest relative, has only two CH2 groups).31 However,
this experiment was not without its issues. Neither -OH proton appeared coupled to anything;
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there were some extremely wide signals around the 2.90-3.0 ppm region, but due to the presence
of the C-19 proton, it was difficult to tell if that was the signal of only one proton or of two
protons crowded together (Figure S12). Additionally, insufficient signal-to-noise prevented us
from obtaining an interpretable 13
 C spectrum, so while any carbons that had HSQC or HMBC
couplings could be identified, anything that had no homonuclear or heteronuclear proton
associations became invisible. Thus, the carbon at C-4 had no confirmed chemical shift value
because it had no HMBC or H2BC correlations (Figure 13).

Figure 13: Key NMR correlations (COSY - green, HMBC - pink) in dDMSO.
Given the HMBC signals between C-1, C-2, and C-3, the COSY correlation between C-2
and the NH, the prior data in MeOD, and the similarity of the MS/MS and NMR data to that of
nocamycin I, the chemical identity of the carbon at C-4 is likely that of an alkene/𝛼-carbon,
though

its

actual

identity

and shift value

cannot

be confirmed based

on the

experimentally-obtained data.
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Confirmation of Experimental Chemical Shift Assignments - DFT in Spartan ‘18
To confirm that the proposed structure was correct, chemical shift calculations utilizing
density functional theory were performed in Spartan ‘18 in order to compare the
experimentally-determined value with the calculated value of each nucleus. The results of those
calculations as compared to the experimental shifts in MeOD are shown below (Figure 14):

Figure 14: Comparison of experimental chemical shift values (MeOD) to calculated values. The
proton values for C-19 (2.2, 2.8) are a paler color because they had no experimental equivalent.
The calculated and experimental carbon shift values were overall in agreement for the tricyclic
portion of the molecule and slightly less in agreement for the olefinic middle portion of the
molecule. The calculated proton shifts did not appear to follow a pattern in terms of which parts
of the molecule had more accurate values. Overall, the calculated values did agree with the
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experimentally determined values, especially for the carbon spectrum. The dDMSO comparisons
followed a largely similar trend (Figure 15):

Figure 15: Comparison of experimental chemical shift values (dDMSO) to calculated values.
The carbon value for C-4 (102.1) is a paler color because it had no experimental equivalent.
Several of the experimental 13
 C chemical shift values in the olefinic section of the molecule were
more similar to the calculated values than their counterparts measured in MeOD, namely C-5 and
C-8. The proton shifts were marginally further from the calculated values in dDMSO, but the
results in Figure 15 still represent a good confirmation of the structure of nocamycin O.
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Residual Analysis of Density Functional Calculations
To ensure that the results of the density functional calculations could be considered
accurate and that there was not an unknown source of systematic error present in the protocol,
residual analysis was performed comparing the calculated chemical shift values to the
experimental values in both MeOD and dDMSO (Figure 16):

Figure 16: Residual analysis comparing the calculated chemical shifts to the experimental
values. All trendlines follow the linear least squares fit model and R2 values closer to zero are
indicative of less correlation between chemical shift value and magnitude of error.
The residual analysis of the calculated and experimental values reveals no significant or
worrying trends in the data; while the residual values for the carbon shifts do get larger as the
chemical shift values increase, the graph, the trendline and the R2 value show that this error is not
systematic (i.e. all positive errors or all negative errors). Thus, the protocol can be considered
reliable and the calculated chemical shift values that it generates can be considered accurate.
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Confirmation of Novelty - Comparison of Nocamycin I and Nocamycin O
Perhaps the most important part of the study of this compound is its confirmation as a
novel compound. Thus, a comparison study between nocamycin O and nocamycin I (its most
chemically similar relative) was conducted to determine if there were any significant and/or
obvious differences in data collected for the two compounds. This study was done using data
analysis of previously collected NMR data for nocamycin I and density functional calculations to
generate calculated chemical shift values for nocamycin I.31 A table comparing the
experimentally derived chemical shift values of nocamycin I and nocamycin O in MeOD is
shown below (Figure 17):

Figure 17: Comparison of experimental chemical shift values for nocamycin I (from Mo et. al.
2017) and nocamycin O (both in dDMSO). Proton shift differences of greater than 0.4 ppm and
carbon shift differences of greater than 3 ppm have been highlighted.
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As shown in Figure 17, C-2, C-5, C-6, C-7, C-9, C-19, and C-23 have marked differences in
either their carbon or proton chemical shifts. The differences in chemical shift values seen in the
olefinic section (C-5 to C-9) of the molecule likely have nothing to do with structural changes to
the compound but rather conformational changes and a subsequent difference in the environment
of these carbons in space. This theory was supported by the differences seen in the
conformations best supported by the density functional calculations performed on nocamycin I
and nocamycin O, as those conformations appeared to be quite different (Figure 18).

Figure 18: Conformational differences between best conformer of nocamycin O (top) and
nocamycin I (bottom). Skeletal structures included for clarity.
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The theory that nocamycin O adopts a novel conformation as compared to nocamycin I,
and is therefore a novel molecule, is further supported by the additional ROESY spectrum
gathered for the compound (Figure 19):

Figure 19: ROESY (2D proton correlation) spectrum for nocamycin O.
Though there is a considerable amount of t2 and t1 noise confounding the readings closer to the
diagonal, quite a few interesting observations can be made based on the data further away from
it. Notably, both 5.65 ppm (C-9) and 0.92 ppm (C-12) appear to be correlated with protons that
are structurally very far away from them (Figure 20):
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Figure 20: All ROESY correlations present on the spectrum in dDMSO. Purple arrows represent
true NOE, while black arrows represent artifact that is also seen on the TOCSY (Figure S14).
C-9 (5.65 ppm) appears to be correlated with C-26 (3.70 ppm), C-10 (2.75 ppm) appears to be
correlated with C-2 (3.32 ppm), and C-12 (0.92 ppm) appears to be correlated with C-23 (3.38
ppm), none of which are structurally near each other at all. None of these three key correlations
appear on the TOCSY either, so it is unlikely that the correlations are artifacts or errors.
Therefore, they must be spatially close to each other, as that is the only explanation for the
signals correlations. These observations point to a unique conformation of nocamycin O similar
to that shown in Figure 18 (though not exactly like that, as that conformation would make the
correlation of C-26 and C-9 very unlikely). This is overwhelmingly due to the addition of the
-OH group, which allows different and/or previously unobserved hydrogen bonding
opportunities, increasing the likelihood that nocamycin O is a novel antibiotic.
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Discussion
Structure Confirmation of Nocamycin O
The two rounds of experimental NMR data acquisition (in MeOD and then dDMSO)
each individually confirmed certain aspects of the compound’s structure. The MeOD run
contained 26 different carbon signals (plus an additional one that was eventually discovered to be
residual formic acid from the HPLC extraction), which supported the structure based on the
significant genetic similarity between nocamycin O and nocamycin I (discovered through the
analysis of the biosynthetic gene cluster) as well as the MS results (Figure 3). However, the lack
of proton signals at C-19 made it difficult to confirm the presence of the -OH group at C-23,
which was also suggested by the 16-amu mass difference between the MS results for nocamycin
I and nocamycin O. Due to this lack of coupling and resulting ambiguity of which shift value
belonged to C-19 and which belonged to C-23 (the MeOD shift values at those positions were
46.0 and 61.1 ppm, and 61.1 was first incorrectly assigned to C-19), more data collection was
deemed necessary. The second data collection was done in dDMSO after a brief solvation in
MeOH to exchange the protons back, and this time there was enough information to confirm the
identities of C-19 and C-23, but no shift at all was seen for C-4 due to insufficient reach of the
HMBC couplings and lack of a decent 13
 C spectrum due to poor signal-to-noise ratio (Figure 13).
Though the inability to confirm C-4 in dDMSO was undesirable, the restoration of the CH2 at
C-19 means that the tricyclic structure of the upper portion of the molecule as well as everything
from C-5 onward can be fairly confirmed via the HMBC and COSY correlations in dDMSO,
which are more extensive than those seen in MeOD (Figures 11 and 13). However, other than the
singular NH coupling seen in the ROESY spectrum (Figure 19), no other heteroatomic couplings
appear to be observed on either of the HMBC or H2BC spectra. It is somewhat likely that some
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additional proton exchange may still be present in the sample via hydrogen bonding (especially
at the -OH attached to C-5), thus rendering some or all of the -OH groups invisible on said
spectra. Even though the spectrum mostly confirms the predicted structure (and agrees with the
MS data) further NMR spectrometry analysis should be conducted on the compound (specifically
a new HMBC of the compound that contains the missing -OH groups, as this is the only
spectrum they are likely to appear on) to ensure that this conclusion is correct and to visualize all
of the peaks seen in the MeOD and dDMSO experiments together in one comprehensive set of
spectra.

DFT Calculations
The density functional theory calculations were additionally helpful for solving the issue
of whether the shift at C-23 was 46 or 61 ppm. However, the amount of error present for other
parts of the molecule did begin to raise questions about the validity of the protocol. While most
of the carbon shift calculations were within the acceptable error range, the approximations were
noticeably bad for C-5 through C-8 (the olefinic section of the molecule), as well as for many of
the proton shifts. An acceptable margin of error for this protocol (as defined by the authors) is
approximately 4-5 ppm for carbon shifts and less than 0.2 ppm for proton shifts, and there were a
few carbon shift values that were off by 10 ppm or more.32 While there does not appear to be any
systematic error associated with the protocol, the approximations for the carbon shifts also
appear to get less accurate as the experimental shift value increases, a trend that is more
noticeable in the dDMSO residual plot but is present in both (Figure 16). There are several
possible reasons for these inaccuracies; those which are most relevant here are conformational
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effects on the experimental results, accuracy of the calculations and its impact on the Boltzmann
weight assigned by the program, and the complex nature of the calculation of proton spectra.
Possibly the factor having the largest impact on the accuracy of the DFT calculations is
conformational change in the experimental sample, which may be solvent-related or not. As a
molecule with a fair amount of free rotation and cis/trans alkene options, nocamycin O has
thousands of possible conformations. Its possibilities are somewhat restricted due to the
ring-locked conformation of the upper region of the molecule, but the olefinic section of the
molecule has numerous possible conformations and shapes. Density functional theory is also
known to be inaccurate in measuring the shifts of alkenes and alkynes specifically, likely
because it doesn’t account for these possible conformational differences.33 Additionally,
differences in shift values for cis and trans forms of the same alkene can be between 0.2 and 0.4
ppm, while carbon shifts have an even larger margin of error.34 The DFT calculations were also
performed in the gas phase, which ignores any effects the solvent could possibly have on the
conformation of the molecule. Thus, it is likely that the conformational distribution for
nocamycin O is different in the gas phase and the solvated phase, resulting in particularly large
errors in the most conformationally flexible region.
Inaccuracies created by the program also include errors stemming from the accuracy of
the model that the calculations favor as well as the Boltzmann weight determined by the program
in the final step. If the Boltzmann weight in the gas phase is different from the actual
conformational distribution, this could result in an inaccurate approximation of the chemical shift
values for those conformationally diverse areas, on the order of 5-8 ppm.32 The Boltzmann
weight seen in silico can also have a great effect on the calculated J values (coupling constants)
which are helpful for determining the splitting and chemical identity of peaks in proton
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spectra.32,35 This is important for the accuracy of the proton spectrum because the coupling
constants are the second derivatives of the energy with respect to the nuclear magnetic moment
μ. This quantity is determined by the program solely using the electronic structure of the
molecule, which is extremely conformation-dependent.19,36 Thus, the proton spectra are more
likely to be incorrect if solvent effects on molecular conformation are not taken into account. The
carbon spectrum does not appear to be as sensitive to this, though the increase in residual error as
the 13
 C shift values increase does represent a possibly problematic issue with the protocol.
Overall, the DFT calculations represent a decent confirmation of the structure of nocamycin O,
but the values only appear trustworthy for the non-olefinic portions of the 13
 C spectrum. To
ensure accuracy of the calculations and determine whether solvent interaction really has a large
effect on conformation and on the calculated shift values, the calculations should be performed
again in Spartan ‘18 under polar solvent conditions instead of in the gas phase.

Nocamycin O as a Novel Member of the Nocamycin Family
Perhaps the most successful portion of this thesis was the confirmation of nocamycin O
as a new compound and a member of the nocamycin family. The analysis of the experimental
NMR shift values for nocamycin O and nocamycin I revealed no large differences in a
considerable portion of the molecule, indicating that the molecules are definitely chemically
similar (Figure 17). However, certain areas of the molecule exhibited extremely large differences
in shift values, namely C-2, C-5, C-6, C-7, C-9, C-19, and C-23. Most notably, the carbon shift
value at C-23 increased nearly 38 ppm from nocamycin I to nocamycin O, while the proton shift
value increased by nearly 2 ppm. The standard shift for a methyl group (C-23 identity in
nocamycin I) is around 10-15 ppm, though C-23 is understandably a bit higher due to its
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surrounding oxygen atoms. The carbon shift value for an RCH2OH methylene carbon is between
37
50 and 90 ppm; the C-23 value for nocamycin O falls right into this range at 59.58 ppm.
This

supports a change in the chemical identity of C-23, and it also supports the idea that the addition
at C-23 is an -OH group. The 16-amu difference in the MS data for the two compounds basically
confirms this idea, because that would correspond to an identical molecule with one additional
oxygen atom (Figure 3).
Other marked changes include the drastic differences seen in the olefinic section of the
molecule (C-5, C-6, C-7, and C-9). Each of these carbons has a shift differential between 5 and
10 ppm, a significant amount of difference to be sure, but not enough to indicate an additional
atom in the region.37 Instead, the difference in chemical shifts at these positions is more likely to
be a result of a change in the chemical environment directly adjacent to the nuclei. The
experiment used to detect these changes was a ROESY spectrum (Figure 19). Our ROESY
experiment detected several interesting interactions between structurally distant parts of the
nocamycin O molecule. C-12 (0.92 ppm) appears to be correlated with at least one of the protons
in the CH2 group at C-23 (3.38 ppm), and C-9 (5.65 ppm) and C-26 (3.70 ppm) are also
correlated, as well as C-10 (2.75 ppm) and C-2 (3.32 ppm). As these nuclei are too far apart to
couple on anything dependent on bond interaction (i.e. an HMBC or H2BC), the only
explanation for this coupling is that magnetic transfer is occurring through spatial association
between the nuclei. The DFT calculations support this association as correct; the collapsed
conformation of nocamycin O appears to be more stable than the linear, stretched-out
conformation that nocamycin I favors. The linear conformation also would not allow the
association of any of these three pairs, because they are extremely far apart in the linear
conformation (Figure 18). This in conjunction with the drastic differences seen between the
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experimental spectra for nocamycin O and nocamycin I point to nocamycin O being a closely
related but novel member of the nocamcyin antibiotic family.

Conclusion
This thesis sought to fully elucidate the structure of nocamycin O, a novel antibiotic,
using experimental and theoretical methods to confirm its place in the nocamycin family and also
its distinct differences from all known members of said family. The experimental NMR data
confirmed its novelty (especially when compared to its structurally similar analog nocamycin I),
but there were several holes in the structure data that will have to be addressed in order to
definitively confirm the correct structure. Chemical shift calculations served to confirm that most
of the 13
 C shift assignments made experimentally were correct; the calculated proton shift values
were less accurate, and calculations should be re-run in a polar solvent environment to determine
if that has any effect on the accuracy of the proton shift approximations. Finally, a combination
of both of these elements helped to further prove the novelty through spatially-dependent proton
couplings (ROESY) present on the spectrum for nocamycin O that were not present for
nocamycin I, as well as conformer analysis using DFT that showed extremely different preferred
geometries for the two molecules.
Through this structural analysis, nocamycin O is shown to be a novel member of the
nocamycin family. Given that other members of this family, as well as other tetramic
acid-derived compounds like streptolydigin, have potent antibacterial effects due to their
inhibition of RNA polymerase, this points to nocamycin O as an exciting area for future study as
well as a potentially important antibiotic for use in the field of medicine.15,16
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Supplementary Figures
Section 1: MeOD NMR Data

Figure S1: 1H-NMR spectrum of nocamycin O in MeOD.
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Figure S2: 13
 C-NMR spectrum of nocamycin O in MeOD.
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Figure S3:2D COSY spectrum of nocamycin O in MeOD.
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Figure S4: 2D HSQC spectrum of nocamycin O in MeOD.
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Figure S5: 2D H2BC spectrum of nocamycin O in MeOD.
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Figure S6: 2D HMBC spectrum of nocamycin O in MeOD.

Figure S7: Comprehensive correlation table of all correlations/couplings seen in MeOD.
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Section 2: dDMSO NMR Data

Figure S8: 1D 1H-NMR spectrum for nocamycin O in dDMSO.
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Figure S9: 2D HSQC spectrum for nocamycin O in dDMSO.
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Figure S10: 2D COSY spectrum for nocamycin O in dDMSO.
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Figure S11: 2D H2BC spectrum for nocamycin O in dDMSO.
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Figure S12: 2D HMBC spectrum for nocamycin O in dDMSO.
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Figure S13: 2D ROESY spectrum for nocamycin O in dDMSO.
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Figure S14: 2D TOCSY spectrum for nocamycin O in dDMSO.
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Figure S15:Comprehensive correlation table of all correlations/couplings seen in MeOD.
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